Search

Search Results

• 

  Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

  M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

  278-285

  17-03-2014

  Published: 17 March 2014

  2468

  PDF: 1324
• 

  Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease

  S. Piantoni, L. Andreoli, F. Allegri, P.L. Meroni, A. Tincani

  307-313

  11-12-2012

  Published: 11 December 2012

  2090

  PDF: 1152
• 

  Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

  C. Nalli, L. Andreoli, M. Motta, G.L. Norman, Z. Shums, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, A. Meini, V. Medeghini, T. Avcin, P.L. Meroni, A. Tincani

  91-96

  Published:

  1082

  PDF: 708

• The role of nailfold videocapillaroscopy in Raynaud’s phenomenon monitoring and early diagnosis of systemic sclerosis

  M. Cutolo, C. Pizzorni, M. Meroni, G. Zampogna, C. Ferrone, E. Alessandri, F. Ravera, A. Sulli

  237-247

  Published:

  1548

  PDF: 4736

• Health related quality of life assessment in patients with systemic sclerosis

  R. Gualtierotti, L. Scalone, F. Ingegnoli, P. Cortesi, C. Lubatti, S. Zeni, P.L. Meroni

  210-214

  Published:

  1120

  PDF: 903

• Subpopulations of anti-β2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β2glycoprotein I

  L. Andreoli, C. Nalli, M. Motta, G.L. Norman, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, T. Avcin, P.L. Meroni, A. Tincani

  189-194

  Published:

  1018

  PDF: 593

• Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive?

  L. Andreoli, F. Pregnolato, R.W. Burlingame, V. Fanelli, F. Allegri, A. Radice, C. Corace, R.A. Sinico, A. Tinconi, P.L. Meroni

  185-191

  Published:

  1085

  PDF: 1050

• Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies

  M. Frassi, A. Brucato, I. Cavazzana, F. Franceschini, D. Faden, M. Motta, A. Doria, R. Cimaz, M.P. Pisoni, M. Muscarà, G. Castellino, G. Brambilla, P.L. Meroni, R. Cattaneo, C. Biasini Rebaioli, C. Antonioli, G. Balestrieri, A. Tincani

  298-304

  Published:

  1320

  PDF: 891